Natural products for the treatment of hypertrophic scars: Preclinical and clinical studies
- PMID: 39296083
- PMCID: PMC11408005
- DOI: 10.1016/j.heliyon.2024.e37059
Natural products for the treatment of hypertrophic scars: Preclinical and clinical studies
Abstract
Hypertrophic scarring (HS) is a complication of wound healing that causes physiological and psychological distress in patients. However, the possible mechanism underlying HS is not fully understood, and there is no gold standard for its treatment. Natural products are more effective, economical, convenient, and safe than existing drugs, and they have a wide application prospect. However, there is a lack of literature on this topic, so we reviewed in vivo, in vitro, and clinical studies and screened natural products showing beneficial effects on HS that can become potential therapeutic agents for HS to fill in the gaps in the field. In addition, we discussed the drug delivery systems related to these natural products and their mechanisms in the treatment of HS. Generally speaking, natural products inhibit inflammation, myofibroblast activation, angiogenesis, and collagen accumulation by targeting interleukins, tumor necrosis factor-α, vascular endothelial growth factors, platelet-derived growth factors, and matrix metalloproteinases, so as to play an anti-HS effects of natural products are attributed to their anti-inflammatory, anti-proliferative, anti-angiogenesis, and pro-apoptotic (enhancing apoptosis and autophagy) roles, thus treating HS. We also screened the potential therapeutic targets of these natural compounds for HS through network pharmacology and constructed a protein-protein interaction (PPI) network, which may provide clues for the pharmacological mechanism of natural products in treating this disease and the development and application of drugs.
Keywords: Drug discovery; Hypertrophic scars; Mechanisms; Natural products; Traditional Chinese medicine.
© 2024 Published by Elsevier Ltd.
Conflict of interest statement
The authors declare the following financial interests/personal relationships which may be considered as potential competing interests:Jing Guo reports financial support was provided by 10.13039/501100001809National Natural Science Foundation of China. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures





Similar articles
-
Traditional Chinese medicine for hypertrophic scars-A review of the therapeutic methods and potential effects.Front Pharmacol. 2022 Oct 10;13:1025602. doi: 10.3389/fphar.2022.1025602. eCollection 2022. Front Pharmacol. 2022. PMID: 36299876 Free PMC article. Review.
-
Centella triterpenes cream as a potential drug for the treatment of hypertrophic scar through inhibiting the phosphorylation of STAT3: A network pharmacology analysis and in vitro experiments.J Cosmet Dermatol. 2023 Dec;22(12):3511-3519. doi: 10.1111/jocd.15883. Epub 2023 Aug 10. J Cosmet Dermatol. 2023. PMID: 37563868
-
Transient exposure to tumor necrosis factor-alpha inhibits collagen accumulation by cultured hypertrophic scar fibroblasts.J Surg Res. 1999 Nov;87(1):134-41. doi: 10.1006/jsre.1999.5747. J Surg Res. 1999. PMID: 10527715
-
Transdermal delivery of Protocatechuic aldehyde using hyaluronic acid/gelatin-based microneedles for the prevention and treatment of hypertrophic scars.Eur J Pharm Biopharm. 2023 Mar;184:202-213. doi: 10.1016/j.ejpb.2023.02.003. Epub 2023 Feb 10. Eur J Pharm Biopharm. 2023. PMID: 36773724
-
Evidence of Potential Natural Products for the Management of Hypertrophic Scars.J Evid Based Integr Med. 2024 Jan-Dec;29:2515690X241271948. doi: 10.1177/2515690X241271948. J Evid Based Integr Med. 2024. PMID: 39196306 Free PMC article. Review.
Cited by
-
Epigallocatechin-3-gallate therapeutic potential in human diseases: molecular mechanisms and clinical studies.Mol Biomed. 2024 Dec 27;5(1):73. doi: 10.1186/s43556-024-00240-9. Mol Biomed. 2024. PMID: 39725830 Free PMC article. Review.
-
Comparative effectiveness of plant-derived compounds in keloid management: a review.Front Pharmacol. 2025 Jul 16;16:1576851. doi: 10.3389/fphar.2025.1576851. eCollection 2025. Front Pharmacol. 2025. PMID: 40741005 Free PMC article. Review.
References
Publication types
LinkOut - more resources
Full Text Sources